What's new? Log in Free sign up

OrganiGram (OGI)

Company Profile

Company profile

Ticker

OGI

Exchange

Website

www.organigram.ca

CEO

Ms. Beena G. Goldenberg

Incorporated

Canada (Federal)

Location

New Brunswick, Canada

Fiscal year end

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co. • Teva Pharmaceutical Industries Limited • Abbott Laboratories • Eli Lilly and • Bristol-Myers Squibb • Viatris • AbbVie • Bausch Health Companies ...

Former names

ORGANIGRAM HOLDINGS INC, ORGANIGRAM HOLDINGS INC.

SEC CIK

Corporate docs

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

OGI stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

Current report (foreign)

Organigram Global to Host the OG Investor Session, its Inaugural Virtual Event for Investors, and Announcement of Name Change on TSX and NASDAQ

Organigram Enters U.S. Through Acquisition of Collective Project Beverages

Organigram Unveils Bold New Brand Identity Reflecting Market Leadership Position in Canada and Growing International Presence

Current report (foreign)

Notice of Annual General and Special Meeting of Shareholders

Organigram Closes Third Tranche of Previously Announced BAT Private Placement Investment

Current report (foreign)

Current report (foreign)

Annual report (Canada) (amended)

Transcripts

View all

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Latest ownership filings

View all

BT DE Investments Inc.

BT DE Investments Inc.

BT DE Investments Inc.

BT DE Investments Inc.

BT DE Investments Inc.

BT DE Investments Inc.

ETF MANAGERS GROUP, LLC

ETF MANAGERS GROUP, LLC

BT DE Investments Inc.

ETF MANAGERS GROUP, LLC

Financial summary

Financial statements Chart OGI financial data

Quarter (USD)	Sep 24	Sep 23	Aug 22	Aug 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Sep 24	Sep 23	Aug 22	Aug 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from OrganiGram earnings reports.

Institutional ownership, Q4 2024

OGI institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	82	74	+10.8%
Opened positions	16	73	-78.1%
Closed positions	8	1	+700.0%
Increased positions	15	1	+1400.0%
Reduced positions	17	0	NEW

13F shares	Current	Prev Q	Change
Total value	11.14 bn	12.85 bn	-13.3%
Total shares	39.64 mm	39.85 mm	-0.5%
Total puts	46.80 k	43.70 k	+7.1%
Total calls	177.70 k	220.90 k	-19.6%
Total put/call ratio	0.3	0.2	+33.1%

Largest owners	Shares	Value	Change
BT DE Investments	32.57 mm	$49.18 mm	0.0%
Toroso Investments	1.72 mm	$2.77 bn	-11.6%
Renaissance Technologies	914.65 k	$1.47 bn	+2.4%
Arrowstreet Capital, Limited Partnership	721.33 k	$1.15 bn	NEW
AdvisorShares Investments	715.95 k	$1.15 bn	-3.5%
Millennium Management	645.78 k	$1.04 bn	-49.3%
BMO Bank of Montreal	459.86 k	$734.85 mm	+0.3%
Dimensional Fund Advisors	359.74 k	$579.18 mm	+13.8%
Baader Bank	250.00 k	$399.83 mm	-1.1%
GS The Goldman Sachs Group, Inc.	168.75 k	$271.69 mm	+14.8%

Largest transactions	Shares	Bought/sold	Change
Arrowstreet Capital, Limited Partnership	721.33 k	+721.33 k	NEW
Millennium Management	645.78 k	-627.44 k	-49.3%
Toroso Investments	1.72 mm	-225.18 k	-11.6%
Two Sigma Investments	130.48 k	-189.01 k	-59.2%
UBS UBS	108.03 k	+107.16 k	+12204.4%
Dimensional Fund Advisors	359.74 k	+43.72 k	+13.8%
Two Sigma Advisers	86.02 k	-39.80 k	-31.6%
Citadel Advisors	39.44 k	+39.42 k	+187714.3%
Group One Trading	0.00	-35.39 k	EXIT
Oxford Asset Management	31.35 k	+31.35 k	NEW

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

News

From Benzinga Pro

Cannabis Stock Gainers And Losers From April 11, 2025

Bullish Sentiment Across The Cannabis Space - Check Full Movers For April 9, 2025

Marijuana Stock Movers For April 7, 2025

Marijuana Stock Movers For April 4, 2025

This Week In Cannabis: Trump Policy Updates, Corporate Moves, Regulatory Shifts And Product Innovations

Press releases

From Benzinga Pro

New Abacus Data Poll Reveals that Most Canadians See Cannabis as a Key Pillar of Canada's Economic Future

Clear majority believes Canada's $7.4 billion legal cannabis industry should be empowered to grow amid rising global trade tensions Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"),

Organigram Global to Host the OG Investor Session, its Inaugural Virtual Event for Investors, and Announcement of Name Change on TSX and NASDAQ

Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram Global"), the cannabis leader in Canada by market share, is pleased to announce its inaugural virtual investor event, the OG Investor Session,

Organigram Enters U.S. Through Acquisition of Collective Project Beverages

Acquisition Marks Commercial Market Entry in the Fast-Growing Hemp-Derived THC Beverage Category in the U.S. and the Emerging Canadian Cannabis Beverage Category Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the

Organigram Unveils Bold New Brand Identity Reflecting Market Leadership Position in Canada and Growing International Presence

Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of Name Change to Organigram Global Inc.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.